{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Cell Therapy - Falling short of its potential?","description":"Despite major investment in the field, few cell therapies have gained regulatory approval with limited commercial success. The success of therapeutic products is defined by three factors: safety, efficacy and scalability. Achieving these for cell therapy presents new challenges; overcoming transplant rejection (and GvHD in the case of immune cells), producing and culturing functional cells and developing an off-the-shelf therapy with a scalable manufacturing process. If you'd like to view the original article then follow the link below:  https:\/\/www.ddw-online.com\/therapeutics\/p323014-cell-therapy-falling-short-of-its-potential.html You can also download the original article pdf here: https:\/\/www.ddw-online.com\/media\/32\/136359\/(6)-cell-therapy.pdf For more information on Drug Discovery World, head to: https:\/\/www.ddw-online.com ","author_name":"The Drug Discovery World Podcast","author_url":"https:\/\/www.ddw-online.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/12640406\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/61722497"}